Searched for
DTAB RECOMMENDATION
Pregabalin moved to Schedule H1 as centre cracks down on drug misusePregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...- Experts back OTC access to NRT across all formats and dosages, including 2 mg and 4 mg, as India struggles with a Tobacco quit success rate under 5%The report highlights the significant economic burden of tobacco use, particularly among low-income households, and underscores how reducin...
- Monitor presence of potentially carcinogenic chemical in Ranitidine: DCGI to drug controllersThe DCGI has directed state and UT drug controllers to monitor levels of the potentially carcinogenic NDMA in Ranitidine, an antacid. This ...
- Panel to take a call on doorstep medicine deliveryIndia's drug advisory body is considering the future of doorstep medicine delivery, initiated during the Covid pandemic. The All-India Orga...
- More fixed-dose combo drugs may enter ban listThe Indian government recently banned 156 fixed-dose combination drugs, citing health risks. An expert committee found these combinations l...
- Govt bans 156 fixed-dose combo drugs over risksFDCs are medicines that combine two or more drugs into a single dosage. The union health and family welfare ministry on Thursday issued a g...
- Preventing misleading claims: Ads for diabetes, oncology drugs may need approvalThe government is looking to regulate advertisements for anti-diabetes, sex hormone, and oncology drugs by amending the Drugs and Cosmetics...
- India's drug regulator cracks down on antibiotic misuse, seeks list of licensed combinationsIndia's drug regulator has directed state counterparts to provide a list of antibiotic combinations licensed for manufacturing and marketin...
- Health Ministry prohibits sale of Ketoprofen and Aceclofenac to conserve vulturesIn a boost to conserve vultures in the country, the health ministry has prohibited sale of two veterinary drugs-Ketoprofen and Aceclofenac....
- Soon you may need doctor's prescription for cough syrupsThe Drugs Technical Advisory Board (DTAB), India's apex drug advisory body, in its meeting last month was also considering a proposal for e...
- Lens on fixed-dose combination drugs containing vitamins, mineralsA committee had been set up under the chairmanship of CK Kokate, former vice-chancellor of KLE University, Belgaum, to review the safety, e...
- DTAB recommends granting licence to manufacture, stock new drugs, jabs under clinical trialBased on the recommendation, the Drugs Controller General of India (DCGI) has sent a draft proposal to the Union Health Ministry for approv...
- Government prohibits 328 fixed dose combinationsThe ban is effective immediately and may shave off over Rs 1,500 crore from India’s Rs 1.18 lakh crore pharmaceutical industry
- Health ministry to ban 328 combination medicines over safety concernsET has viewed parts of the latest ban notifications, which a senior ministry official confirmed would be notified this week.
- Panel recommends ban on 343 fixed dose combination medicinesThis report will be sent to the health ministry in the next two weeks, following which the government will decide the fate of these drugs, ...
- SC for relook into 349 FDC medicines by drug advisory boardThe FDC were banned by the Centre on the grounds that they involved "risk" to humans and safer alternatives were available.
- Supreme Court asks drugs advisory body to decide fate of over 334 banned combination medicinesCompanies can make and sell the 349 contested fixed dose combination drugs (FDCs) while Drugs Technical Advisory Board (DTAB) deliberates o...
- Delhi High Court refuses to vacate stay on drug banDelhi HC has declined to vacate the stay earlier granted to certain drug brands banned by the health ministry, and said it would hear all f...
- PCMA opposes plan to ban PET container packing for medicinesPCMA has opposed the recommendations of the Health Ministry's DTAB demanding ban on use of PET containers for the packaging of pharmaceutic...
- Health ministry to review ban on Pioglitazone tomorrowIn the wake of opposition from industry and medical fraternity to the ban on anti-diabetes drug Pioglitazone, DTAB will review the decision...
Load More
